Operating

Other Noncash Income (Expense)

Moderna Other Noncash Income (Expense) increased by 77.8% to -$6.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 200.0%, from -$2.00M to -$6.00M.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ1 2020
Last reportedQ1 2026May 1, 2026

How to read this metric

Large fluctuations may indicate one-time accounting adjustments or non-recurring non-cash events that require further investigation.

Detailed definition

This category aggregates various non-cash items that do not fit into standard categories like depreciation or stock-base...

Peer comparison

Standard line item in cash flow statements; peers use this to capture miscellaneous non-cash accounting impacts.

Metric ID: operating_other_noncash_income_expense

Historical Data

17 periods
 Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.00$0.00$0.00-$15.00M-$21.00M$4.00M$8.00M-$37.00M-$3.00M-$4.00M$0.00-$54.00M-$2.00M-$34.00M-$14.00M-$27.00M-$6.00M
QoQ Change-40.0%+119.0%+100.0%-562.5%+91.9%-33.3%+100.0%+96.3%<-999%+58.8%-92.9%+77.8%
YoY Change+153.3%-76.2%-175.0%-150.0%+100.0%+33.3%-750.0%+50.0%-200.0%
Range-$54.00M$8.00M
Avg YoY Growth-112.7%
Median YoY Growth-76.2%

Frequently Asked Questions

What is Moderna's other noncash income (expense)?
Moderna (MRNA) reported other noncash income (expense) of -$6.00M in Q1 2026.
How has Moderna's other noncash income (expense) changed year-over-year?
Moderna's other noncash income (expense) decreased by 200.0% year-over-year, from -$2.00M to -$6.00M.
What does other noncash income (expense) mean?
Miscellaneous non-cash income or expenses that impact net income but not cash flow.